The chemical class termed BAI-1 Activators encompasses a range of compounds that engage with the brain-specific angiogenesis inhibitor 1 (BAI1) protein or its associated signaling pathways. BAI1 is an adhesion G protein-coupled receptor (GPCR), playing a role in diverse biological processes, including angiogenesis, phagocytosis, and synaptic functions. The activators in this class, while not directly interacting with BAI1, modulate the cellular environment or signaling mechanisms in a manner that can lead to the upregulation or enhanced activity of BAI1. These compounds operate through various mechanisms, impacting different stages or components of the signaling pathways related to BAI1. For instance, some activators may influence intracellular calcium levels, which are crucial for GPCR function, while others might interact with the G-protein signaling cascade, either by activating or inhibiting specific G-proteins that are integral to the signaling pathways associated with BAI1 function.
The diversity of mechanisms seen within BAI-1 activators reflects the complex nature of cellular signaling and the broad biological roles of BAI1. For example, compounds like Forskolin, which activates adenylyl cyclase, impact cAMP levels, thereby indirectly affecting GPCR-mediated signaling. On the other hand, agents like Phorbol 12-myristate 13-acetate (PMA) function by activating protein kinase C, potentially influencing downstream pathways linked to GPCR activity. Similarly, Pertussis Toxin and Cholera Toxin modify G-protein activity, illustrating the wide-ranging approaches these activators take to modulate signaling pathways. This diversity underscores the intricate web of cellular interactions and processes that these compounds engage with, influencing BAI1 activity indirectly. The BAI-1 Activators, therefore, represent a complex and multifaceted chemical class, with each member bringing a unique mode of action to influence BAI1-associated pathways, and by extension, the diverse physiological processes in which BAI1 is involved.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Increases intracellular calcium, potentially influencing GPCR function including those similar to BAI | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylyl cyclase, potentially impacting cAMP levels and indirectly modulating GPCR activity. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
Non-hydrolyzable GTP analog, can activate G-proteins, possibly affecting GPCR-mediated signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C, possibly influencing pathways linked to GPCR function. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
β-adrenergic receptor agonist, may indirectly affect GPCR-related signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Can modulate GPCR activity, possibly impacting signaling pathways relevant to BAI1 function. |